{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T03:01:20Z","timestamp":1780282880367,"version":"3.54.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04789-3","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:46:34Z","timestamp":1776257194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular subtyping of colorectal cancer based on inositol metabolism identifies PLCG2 as a key prognostic biomarker"],"prefix":"10.1186","volume":"26","author":[{"given":"Dandan","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"3","key":"4789_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung HYA, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA-Cancer J Clin"},{"issue":"3","key":"4789_CR2","first-page":"313","volume":"5","author":"Z Luo","year":"2025","unstructured":"Luo Z, Dong X, Wang L, Zheng Y, Wang C, Xie J, Chen X, Zhao L, Xu Y, Cao W, et al. Potential reduction of global colorectal cancer, 1990\u20132021. J Natl Cancer Cent. 2025;5(3):313\u201321.","journal-title":"J Natl Cancer Cent"},{"issue":"4","key":"4789_CR3","first-page":"414","volume":"5","author":"R Liu-Galvin","year":"2025","unstructured":"Liu-Galvin R, Xie Z, Hong YR. Colorectal cancer screening in adults aged 45\u201349: provider availability, CT colonography access, and screening rates. J Natl Cancer Cent. 2025;5(4):414\u201325.","journal-title":"J Natl Cancer Cent"},{"issue":"1","key":"4789_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41575-023-00841-9","volume":"21","author":"CC Murphy","year":"2024","unstructured":"Murphy CC, Zaki TA. Changing epidemiology of colorectal cancer - birth cohort effects and emerging risk factors. Nat reviews Gastroenterol Hepatol. 2024;21(1):25\u201334.","journal-title":"Nat reviews Gastroenterol Hepatol"},{"issue":"2","key":"4789_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338\u201344.","journal-title":"Gut"},{"key":"4789_CR6","doi-asserted-by":"crossref","unstructured":"Martianov AS, Mitiushkina NV, Ershova AN, Martynenko DE, Bubnov MG, Amankwah P, Yanus GA, Aleksakhina SN, Tiurin VI, Venina AR et al. KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas. Int J Mol Sci 2023, 24(5).","DOI":"10.3390\/ijms24054868"},{"issue":"5","key":"4789_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41419-024-06598-6","volume":"15","author":"J Xiao","year":"2024","unstructured":"Xiao J, Yu X, Meng F, Zhang Y, Zhou W, Ren Y, Li J, Sun Y, Sun H, Chen G, et al. Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer. Cell Death Dis. 2024;15(5):326.","journal-title":"Cell Death Dis"},{"issue":"9","key":"4789_CR8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s43018-024-00807-z","volume":"5","author":"X Chu","year":"2024","unstructured":"Chu X, Li X, Zhang Y, Dang G, Miao Y, Xu W, Wang J, Zhang Z, Cheng S. Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms. Nat cancer. 2024;5(9):1409\u201326.","journal-title":"Nat cancer"},{"issue":"7","key":"4789_CR9","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1053\/j.gastro.2021.02.020","volume":"160","author":"W Liu","year":"2021","unstructured":"Liu W, Zhang X, Xu H, Li S, Lau HC, Chen Q, Zhang B, Zhao L, Chen H, Sung JJ, et al. Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal Carcinogenesis. Gastroenterology. 2021;160(7):2395\u2013408.","journal-title":"Gastroenterology"},{"key":"4789_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.nu.06.070186.003023","volume":"6","author":"BJ Holub","year":"1986","unstructured":"Holub BJ. Metabolism and function of myo-inositol and inositol phospholipids. Annu Rev Nutr. 1986;6:563\u201397.","journal-title":"Annu Rev Nutr"},{"key":"4789_CR11","doi-asserted-by":"crossref","unstructured":"Monastra G, Gambioli R, Unfer V, Forte G, Maymo-Masip E, Comitato R. D-Chiro-Inositol and Myo-Inositol Induce WAT\/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2). Int J Mol Sci 2023, 24(8).","DOI":"10.3390\/ijms24087421"},{"issue":"2","key":"4789_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"JA Fresno Vara","year":"2004","unstructured":"Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonz\u00e1lez-Bar\u00f3n M. PI3K\/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30(2):193\u2013204.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"4789_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41467-022-35583-w","volume":"14","author":"MP Trefny","year":"2023","unstructured":"Trefny MP, Kirchhammer N, Auf der Maur P, Natoli M, Schmid D, Germann M, Fernandez Rodriguez L, Herzig P, L\u00f6tscher J, Akrami M, et al. Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy. Nat Commun. 2023;14(1):86.","journal-title":"Nat Commun"},{"issue":"14","key":"4789_CR14","doi-asserted-by":"publisher","first-page":"E2826","DOI":"10.1073\/pnas.1613447114","volume":"114","author":"ES Song","year":"2017","unstructured":"Song ES, Jang H, Guo HF, Juliano MA, Juliano L, Morris AJ, Galperin E, Rodgers DW, Hersh LB. Inositol phosphates and phosphoinositides activate insulin-degrading enzyme, while phosphoinositides also mediate binding to endosomes. Proc Natl Acad Sci U S A. 2017;114(14):E2826\u201335.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4789_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cmet.2025.11.011","volume":"38","author":"J Li","year":"2026","unstructured":"Li J, Lu J, Zheng C, Huang X, Li H, Mai Q, Chen S, Zhou Z, Zhu J, Yu T, et al. Serotonin-licensed macrophages potentiate chemoresistance via inositol metabolic crosstalk in ovarian cancer. Cell Metab. 2026;38(2):331\u2013e349310.","journal-title":"Cell Metab"},{"issue":"1","key":"4789_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-biochem-030222-121901","volume":"93","author":"L Nagpal","year":"2024","unstructured":"Nagpal L, He S, Rao F, Snyder SH. Inositol Pyrophosphates as Versatile Metabolic Messengers. Annu Rev Biochem. 2024;93(1):317\u201338.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"4789_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12967-025-07632-7","volume":"24","author":"P Jiang","year":"2026","unstructured":"Jiang P, Wang M, Zhang C, Li X, Wang Z, Guo Y, Zhang J, Yan W, Xi X. PLCG2 across human disease: genetic variants, signaling mechanisms, and clinical implications. J Transl Med. 2026;24(1):110.","journal-title":"J Transl Med"},{"key":"4789_CR18","doi-asserted-by":"crossref","unstructured":"Chen XM, Liang YB, Zuo JX, Yang ZS, Zhang LY, Zhang XY, Wan P, Ke Y. ZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review). Int J Mol Med 2026, 57(3).","DOI":"10.3892\/ijmm.2026.5729"},{"issue":"34","key":"4789_CR19","first-page":"e2303091","volume":"10","author":"F Li","year":"2023","unstructured":"Li F, Yu J, Pan T, Feng H, Li J, Yu B, Fan Z, Sang Q, Chen M, Zang M, et al. BPTF Drives Gastric Cancer Resistance to EGFR Inhibitor by Epigenetically Regulating the C-MYC\/PLCG1\/Perk Axis. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2023;10(34):e2303091.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"issue":"22","key":"4789_CR20","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1158\/0008-5472.CAN-20-1453","volume":"80","author":"KB Kim","year":"2020","unstructured":"Kim KB, Kim Y, Rivard CJ, Kim DW, Park KS. FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer. Cancer Res. 2020;80(22):5051\u201362.","journal-title":"Cancer Res"},{"issue":"18","key":"4789_CR21","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1038\/s44319-025-00546-x","volume":"26","author":"L Zeng","year":"2025","unstructured":"Zeng L, Zhang X, Xiong Y, Sato K, Hajicek N, Kogure Y, Kataoka K, Ogawa S, Sondek J, Su X. Hyperactive PLCG1 induces cell-autonomous and bystander T cell activation and drug resistance. EMBO Rep. 2025;26(18):4563\u201386.","journal-title":"EMBO Rep"},{"issue":"6","key":"4789_CR22","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1158\/1078-0432.CCR-21-1992","volume":"28","author":"R Cruz-Duarte","year":"2022","unstructured":"Cruz-Duarte R, Rebelo de Almeida C, Negr\u00e3o M, Fernandes A, Borralho P, Sobral D, Gallego-Paez LM, Machado D, Grama\u00e7a J, V\u00edlchez J, et al. Predictive and Therapeutic Implications of a Novel PLC\u03b31\/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer. Clin cancer research: official J Am Association Cancer Res. 2022;28(6):1203\u201316.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"14","key":"4789_CR23","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.7150\/ijbs.98200","volume":"20","author":"X Zhou","year":"2024","unstructured":"Zhou X, Lin J, Shao Y, Zheng H, Yang Y, Li S, Fan X, Hong H, Mao Z, Xue P, et al. Targeting PLCG2 Suppresses Tumor Progression, Orchestrates the Tumor Immune Microenvironment and Potentiates Immune Checkpoint Blockade Therapy for Colorectal Cancer. Int J Biol Sci. 2024;20(14):5548\u201375.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"4789_CR24","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3803\/EnM.2023.1780","volume":"38","author":"TH Roh","year":"2023","unstructured":"Roh TH, Chae MK, Ko JS, Kikkawa DO, Jang SY, Yoon JS. Phospholipase C-\u03b3 as a Potential Therapeutic Target for Graves\u2019 Orbitopathy. Endocrinol metabolism (Seoul Korea). 2023;38(6):739\u201349.","journal-title":"Endocrinol metabolism (Seoul Korea)"},{"issue":"3","key":"4789_CR25","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1158\/1078-0432.CCR-22-3934","volume":"30","author":"N Jain","year":"2024","unstructured":"Jain N, Croner LJ, Allan JN, Siddiqi T, Tedeschi A, Badoux XC, Eckert K, Cheung LWK, Mukherjee A, Dean JP, et al. Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clin cancer research: official J Am Association Cancer Res. 2024;30(3):498\u2013505.","journal-title":"Clin cancer research: official J Am Association Cancer Res"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04789-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04789-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04789-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:29:38Z","timestamp":1780280978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04789-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4789"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04789-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in strict accordance with the ethical principles outlined in the Declaration of Helsinki. It was approved by the Ethics Committee of the Affiliated Hospital with Jiangnan University. As this study involves the analysis of human participant data and\/or tissue samples, we confirm that informed consent was obtained from all individual participants included in the study. The informed consent process clearly informed the participants about the nature, purpose, potential risks, and benefits of the study, and the consent forms were personally signed by the participants or their legally authorized representatives.The subjects involved in this study have all signed written consent to participate in the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"331"}}